EnXray is a development-stage company advancing a Low Energy X-ray (LEXR) sterilization machine that enables on-site, on-demand sterilization of medical devices and consumables at the point of manufacture. The company is carrying out initial product sterilization testing with potential customers and is targeting the medical device manufacturing industry as its first market. It intends to use recent funding for pre-commercialization activities, manufacturing and the commercial launch of LEXR. EnXray is on track for commercial launch by the last quarter of this year. The company recently secured a £2.327m funding package comprising loan and equity. Founded in 2012 and based in Liverpool, the company remains in the development stage. EnXray Ltd is a Liverpool, England development-stage sterilization technology company founded in 2012 by Ed Cappabianca. The company is commercializing a proprietary, patent-pending Low Energy X-ray (LEXR) sterilization technology. Its first target market is the medical device manufacturing industry, aiming to enable on-site and on-demand sterilization as the final step of production. EnXray has installed a first prototype unit at partner SMS Electronics in Beeston and is developing that prototype into a commercial version for demonstrations and validation. The company expects to start product sterilization testing for potential customers in Q4 2016. Recent financing activity and a prior government-backed loan facility are being used to support further development and commercialization of the LEXR technology.

Total raised

$4M

Funding rounds

3

Latest round

Debt Financing

Latest activity

Apr 2017